Following an original approach based on the identification of off-context tissue-specific gene activation in breast cancer, we recently identified the de novo DNA methyltransferase DNMT3B, along with four other genes, as markers of highly aggressive breast cancer subtypes [9]. The gene discussed is DNMT3B; the disease is breast carcinoma.